You are here

leukemia

Galecto buys leukemia drug from Bridge Medicines, drops bone cancer asset in strategic pivot

Fierce Biotech

Mon, 10/7/24 - 11:36 am

Bridge Medicine

BMS’ long-standing leukemia blockbuster stares down its first generic

Pharma Voice

Fri, 07/12/24 - 11:10 am

Bristol Myers Squibb

FDA rejects Xspray's would-be rival to Bristol Myers' Sprycel on dosing, manufacturing concerns

Fierce Pharma

Wed, 07/12/23 - 09:35 am

Bristol Myers Squibb

OCI-led CAR-T leukemia therapy receives €2.5m from EIC

Pharmaphorum

Mon, 02/27/23 - 07:02 pm

Days after halting leukemia drug, Magenta moves to close its doors

Fierce Biotech

Thu, 02/2/23 - 11:11 pm

Magenta Therapeutics

AstraZeneca Will Withdraw Leukemia Drug Lumoxiti From US Market

MPR

Thu, 01/12/23 - 09:23 pm

Rigel bets $230M that Forma's leukemia drug gets in formation with FDA

Fierce Biotech

Tue, 08/2/22 - 11:30 pm

Rigel Pharmaceuticals

Forma Therapeutics

Teva recalls one lot of leukemia med after finding particulates in vial

Fierce Pharma

Wed, 03/30/22 - 11:01 am

Teva Pharmaceutical

product recalls

ASH: Chasing AbbVie and J&J's Imbruvica, BeiGene's Brukinsa fleshes out competitive leukemia data again

Fierce Biotech

Thu, 11/4/21 - 10:27 am

clinical trials

AskBio, Syndax and Catalyst All on the Fast Track

BioSpace

Mon, 06/28/21 - 06:56 pm

fast track status

Catalyst Biosciences

episodic bleeding

Syndax looks to rebound from stinging late-stage failure, uncorking early data for next cancer drug up

Endpoints

Tue, 04/20/21 - 07:35 pm

clinical trials

Bluebird stops studies of sickle cell gene therapy after new cancer cases

BioPharma Dive

Tue, 02/16/21 - 11:19 am

sickle cell disease

clinical trials

OncoImmune nabs $56M round for late-stage COVID-19 tests, leukemia treatment

Fierce Biotech

Wed, 09/9/20 - 10:57 am

Kronos Bio raises $155M in private financing to advance lead leukemia drug into registration study next year

MedCity News

Tue, 08/25/20 - 10:28 am

Gilead Sciences

ElevateBio founds HighPassBio to develop Fred Hutch cell therapy

Fierce Biotech

Tue, 10/1/19 - 10:17 am

Common Serious Side-Effect Of CAR T-Cell Therapy May Be Preventable

Forbes

Mon, 05/28/18 - 01:33 pm

cytokine release syndrome

3 Biotech Stocks With Major Catalysts Incoming

Motley Fool

Fri, 04/20/18 - 12:45 pm

TG Therapeutics

Cara Therapeutics

rheumatoid arthritis

New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’

Stat

Wed, 08/23/17 - 11:41 am

Two cancer drug prices have already been hiked by 8% this year

Marketwatch

Wed, 07/5/17 - 09:35 am

Teva Pharmaceutical

Novartis backs Gamida Cell’s $40M raise to fund a looming PhIII study, marketing and manufacturing prep

Endpoints

Tue, 06/20/17 - 09:20 am

clinical trials

Pages